Results 321 to 330 of about 1,678,722 (395)
Some of the next articles are maybe not open access.

Hyskon induced pulmonary hemorrhage

Journal of Clinical Anesthesia, 1995
Hyskon, a distension medium composed of dextran 70 in 10% dextrose in water, is often used during hysteroscopic procedures. Coagulopathy and pulmonary edema are the most commonly reported side effects encountered during its use. We present the first case report in which a healthy patient developed pulmonary hemorrhage from Hyskon use.
J. M. Kreitzer   +2 more
openaire   +4 more sources

Pulmonary hemorrhage: not only vasculitis

Internal and Emergency Medicine, 2011
A 54-year-old man was admitted to our Unit for evaluation of a 4-week history of worsening dyspnea, mild productive cough, fatigue and chest pain. He also reported some episodes of haemoptysis in the prior month. The patient was affected by congenital bicuspid aortic valve disease associated with aortic root aneurysm, mild-severe aortic regurgitation ...
Silvestri E   +4 more
openaire   +3 more sources

Pulmonary Hemorrhage in the Neonate

Neonatal Network, 2019
A case study of a 37 weeks' gestational age male infant, presenting with bloody fluid orally shortly after birth. The presentation, etiology, diagnosis, and management of pulmonary hemorrhage are addressed.
openaire   +3 more sources

Pulmonary Hemorrhage in the Newborn

Archives of Pediatrics & Adolescent Medicine, 1967
A RELATIVELY neglected factor, which in the newly born may be responsible for adverse pulmonary symptoms, has been pulmonary hemorrhage. Although well recognized, at least as an autopsy finding, the systematic studies of Ahvenainen 1,2 have stood until very recently as the only significant contributions to the subject. 3,4 Much remains to be understood
openaire   +3 more sources

Fatal Pulmonary Hemorrhage

Physical Therapy, 1980
To the Editor: In the October 1979 issue of Physical Therapy, a Clinical Report entitled “Fatal Pulmonary Hemorrhage Associated with Chest Physical Therapy” by Hammon and Martin appeared. I applaud the use of such case reporting to alert and enable other therapists in the field to recognize both positive and potentially harmful treatments.
Colleen M Kigin   +4 more
openaire   +2 more sources

Exercise-induced pulmonary hemorrhage

Veterinary Clinics of North America: Equine Practice, 2003
EIPH is a condition affecting virtually all horses during intense exercise worldwide. The hemorrhage originates from the pulmonary vasculature and is distributed predominantly bilaterally in the dorsocaudal lung lobes. As the condition progresses, the lung abnormalities extend cranially along the dorsal portions of the lung.
Eric K. Birks   +2 more
openaire   +3 more sources

Negative Pressure Pulmonary Hemorrhage

Chest, 1999
Negative pressure pulmonary edema, a well-recognized phenomenon, is the formation of pulmonary edema following an acute upper airway obstruction (UAO). To our knowledge, diffuse alveolar hemorrhage has not been reported previously as a complication of an UAO. We describe a case of negative pressure pulmonary hemorrhage, and we propose that its etiology
David R. Schwartz   +3 more
openaire   +3 more sources

Pathologic approach to pulmonary hemorrhage

Annals of Diagnostic Pathology, 2001
The pathologist's approach to pulmonary hemorrhage is outlined. Most cases fall into those examples of pulmonary hemorrhage caused by localized sites of bleeding, and those examples that fall within the spectrum of diffuse alveolar hemorrhage. The histologic evaluation of pulmonary hemorrhage is outlined including assessment of fresh hemorrhage in ...
Junya Fukuoka   +5 more
openaire   +2 more sources

Pulmonary Hemorrhage in Goodpasture's Syndrome

New England Journal of Medicine, 1976
Goodpasture's syndrome is a distinctive combination of glomerulonephritis and pulmonary hemorrhage mediated by antibodies to the basement membranes of the glomeruli, and probably also of the lungs.1 Although the syndrome is uncommon, it has excited widespread interest because of its conceptual implications for immunology and because it is usually a ...
openaire   +3 more sources

Abciximab and fatal pulmonary hemorrhage

Heart & Lung, 2006
Abciximab, a platelet glycoprotein IIb/IIIa receptor blocker, is a well-known agent in percutaneous coronary intervention because of its antiplatelet, antithrombotic effects, which allow for good outcome. Major bleeding is a well-recognized complication of abciximab therapy, and pulmonary hemorrhage, although infrequent, is a serious, under-recognized,
Fahd Rahman   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy